JOHN OYLER Insider Trading $BGNE BeiGene, Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN OYLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN OYLER. JOHN OYLER is CEO in BeiGene, Ltd. ($BGNE) and Chief Executive Officer in BeiGene, Ltd. ($BGNE).
JOHN OYLER in BeiGene, Ltd.
Trading Symbol: BGNEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN OYLER: Chief Executive Officer, CEO
Holdings: 7,336,253 shares
Current Value: $263,518,208
Latest Transaction: Dec 15 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN OYLER in BeiGene, Ltd.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 15 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Gift | G | 0.00 | 545,597 | 0 | 545,597 | 0 to 545.6 K |
Dec 15 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Gift | G | 0.00 | 545,597 | 0 | 6,790,656 | 7.3 M to 6.8 M (-7.44 %) |
Dec 15 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Gift | G | 0.00 | 1,591,317 | 0 | 7,336,253 | 8.9 M to 7.3 M (-17.82 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 283.80 | 400 | 113,521 | 0 | 400 to 0 (-100.00 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 283.11 | 1,609 | 455,527 | 400 | 2 K to 400 (-80.09 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 282.05 | 4,236 | 1,194,760 | 2,009 | 6.2 K to 2 K (-67.83 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 281.16 | 10,827 | 3,044,160 | 6,245 | 17.1 K to 6.2 K (-63.42 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 280.30 | 3,831 | 1,073,814 | 17,072 | 20.9 K to 17.1 K (-18.33 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 278.92 | 800 | 223,136 | 20,903 | 21.7 K to 20.9 K (-3.69 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 276.88 | 400 | 110,752 | 21,703 | 22.1 K to 21.7 K (-1.81 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 274.42 | 200 | 54,884 | 22,103 | 22.3 K to 22.1 K (-0.90 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 274.08 | 550 | 150,744 | 22,303 | 22.9 K to 22.3 K (-2.41 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 272.74 | 450 | 122,731 | 22,853 | 23.3 K to 22.9 K (-1.93 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 282.87 | 700 | 198,010 | 0 | 700 to 0 (-100.00 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 281.04 | 1,800 | 505,874 | 700 | 2.5 K to 700 (-72.00 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 280.26 | 21,080 | 5,907,883 | 2,500 | 23.6 K to 2.5 K (-89.40 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 279.24 | 5,187 | 1,448,396 | 23,580 | 28.8 K to 23.6 K (-18.03 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 283.80 | 400 | 113,521 | 0 | 400 to 0 (-100.00 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 278.50 | 2,233 | 621,901 | 28,767 | 31 K to 28.8 K (-7.20 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 283.11 | 1,609 | 455,527 | 400 | 2 K to 400 (-80.09 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 282.05 | 4,236 | 1,194,760 | 2,009 | 6.2 K to 2 K (-67.83 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 281.16 | 10,827 | 3,044,160 | 6,245 | 17.1 K to 6.2 K (-63.42 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 280.30 | 3,831 | 1,073,814 | 17,072 | 20.9 K to 17.1 K (-18.33 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 278.92 | 800 | 223,136 | 20,903 | 21.7 K to 20.9 K (-3.69 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 276.88 | 400 | 110,752 | 21,703 | 22.1 K to 21.7 K (-1.81 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 274.42 | 200 | 54,884 | 22,103 | 22.3 K to 22.1 K (-0.90 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 274.08 | 550 | 150,744 | 22,303 | 22.9 K to 22.3 K (-2.41 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 272.74 | 450 | 122,731 | 22,853 | 23.3 K to 22.9 K (-1.93 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 282.87 | 700 | 198,010 | 0 | 700 to 0 (-100.00 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 281.04 | 1,800 | 505,874 | 700 | 2.5 K to 700 (-72.00 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 280.26 | 21,080 | 5,907,883 | 2,500 | 23.6 K to 2.5 K (-89.40 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 279.24 | 5,187 | 1,448,396 | 23,580 | 28.8 K to 23.6 K (-18.03 %) |
Sep 30 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 278.50 | 2,233 | 621,901 | 28,767 | 31 K to 28.8 K (-7.20 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 257.97 | 723 | 186,513 | 0 | 723 to 0 (-100.00 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 256.86 | 300 | 77,057 | 723 | 1 K to 723 (-29.33 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 255.88 | 2,800 | 716,476 | 1,023 | 3.8 K to 1 K (-73.24 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 255.14 | 13,140 | 3,352,505 | 3,823 | 17 K to 3.8 K (-77.46 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 253.71 | 10,312 | 2,616,255 | 16,963 | 27.3 K to 17 K (-37.81 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 257.87 | 266 | 68,593 | 0 | 266 to 0 (-100.00 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 256.82 | 1,100 | 282,506 | 266 | 1.4 K to 266 (-80.53 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 255.64 | 4,642 | 1,186,671 | 1,366 | 6 K to 1.4 K (-77.26 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 254.95 | 12,799 | 3,263,158 | 6,008 | 18.8 K to 6 K (-68.05 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 253.80 | 5,339 | 1,355,033 | 18,807 | 24.1 K to 18.8 K (-22.11 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 252.97 | 7,868 | 1,990,352 | 24,146 | 32 K to 24.1 K (-24.58 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 251.40 | 2,200 | 553,068 | 32,014 | 34.2 K to 32 K (-6.43 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 252.53 | 170 | 42,930 | 0 | 170 to 0 (-100.00 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 251.90 | 3,476 | 875,606 | 170 | 3.6 K to 170 (-95.34 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 250.56 | 6,877 | 1,723,095 | 3,646 | 10.5 K to 3.6 K (-65.35 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 249.73 | 7,116 | 1,777,102 | 10,523 | 17.6 K to 10.5 K (-40.34 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 248.56 | 1,500 | 372,842 | 17,639 | 19.1 K to 17.6 K (-7.84 %) |
Sep 16 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 247.01 | 600 | 148,206 | 19,139 | 19.7 K to 19.1 K (-3.04 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.78 | 2,016 | 473,308 | 0 | 2 K to 0 (-100.00 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.28 | 3,018 | 707,062 | 2,016 | 5 K to 2 K (-59.95 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.70 | 1,455 | 338,578 | 5,034 | 6.5 K to 5 K (-22.42 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 231.52 | 1,905 | 441,046 | 6,489 | 8.4 K to 6.5 K (-22.69 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 230.50 | 3,300 | 760,641 | 8,394 | 11.7 K to 8.4 K (-28.22 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 228.92 | 610 | 139,643 | 11,694 | 12.3 K to 11.7 K (-4.96 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 228.08 | 1,802 | 410,995 | 12,304 | 14.1 K to 12.3 K (-12.77 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 226.97 | 8,019 | 1,820,064 | 14,106 | 22.1 K to 14.1 K (-36.24 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 226.07 | 4,482 | 1,013,258 | 22,125 | 26.6 K to 22.1 K (-16.85 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 224.52 | 1,200 | 269,428 | 26,607 | 27.8 K to 26.6 K (-4.32 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 239.63 | 900 | 215,665 | 0 | 900 to 0 (-100.00 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 238.46 | 1,000 | 238,461 | 900 | 1.9 K to 900 (-52.63 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.27 | 647 | 153,511 | 1,900 | 2.5 K to 1.9 K (-25.40 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 236.12 | 1,904 | 449,580 | 2,547 | 4.5 K to 2.5 K (-42.78 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.98 | 1,228 | 288,555 | 4,451 | 5.7 K to 4.5 K (-21.62 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.28 | 4,290 | 1,005,045 | 5,679 | 10 K to 5.7 K (-43.03 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.86 | 3,401 | 791,969 | 9,969 | 13.4 K to 10 K (-25.44 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 231.92 | 2,959 | 686,250 | 13,370 | 16.3 K to 13.4 K (-18.12 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 230.87 | 3,945 | 910,773 | 16,329 | 20.3 K to 16.3 K (-19.46 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.81 | 42 | 10,198 | 0 | 42 to 0 (-100.00 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.16 | 3,312 | 802,017 | 42 | 3.4 K to 42 (-98.75 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 241.14 | 5,707 | 1,376,172 | 3,354 | 9.1 K to 3.4 K (-62.98 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 240.15 | 2,200 | 528,326 | 9,061 | 11.3 K to 9.1 K (-19.54 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 239.09 | 600 | 143,452 | 11,261 | 11.9 K to 11.3 K (-5.06 %) |
Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.82 | 1,100 | 261,599 | 11,861 | 13 K to 11.9 K (-8.49 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 243.48 | 694 | 168,976 | 0 | 694 to 0 (-100.00 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.96 | 6,700 | 1,627,837 | 694 | 7.4 K to 694 (-90.61 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 241.62 | 2,471 | 597,033 | 7,394 | 9.9 K to 7.4 K (-25.05 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 240.64 | 6,255 | 1,505,215 | 9,865 | 16.1 K to 9.9 K (-38.80 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 239.66 | 10,997 | 2,635,540 | 16,120 | 27.1 K to 16.1 K (-40.55 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 238.86 | 10,568 | 2,524,293 | 27,117 | 37.7 K to 27.1 K (-28.04 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.80 | 3,103 | 737,882 | 37,685 | 40.8 K to 37.7 K (-7.61 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.44 | 4,679 | 1,110,972 | 0 | 4.7 K to 0 (-100.00 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 236.50 | 2,101 | 496,879 | 4,679 | 6.8 K to 4.7 K (-30.99 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 235.22 | 3,845 | 904,411 | 6,780 | 10.6 K to 6.8 K (-36.19 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.45 | 4,798 | 1,124,895 | 10,625 | 15.4 K to 10.6 K (-31.11 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 233.13 | 600 | 139,875 | 15,423 | 16 K to 15.4 K (-3.74 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.34 | 2,000 | 464,678 | 16,023 | 18 K to 16 K (-11.10 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 231.15 | 2,500 | 577,881 | 18,023 | 20.5 K to 18 K (-12.18 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 230.16 | 1,000 | 230,158 | 20,523 | 21.5 K to 20.5 K (-4.65 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.04 | 1,300 | 308,155 | 0 | 1.3 K to 0 (-100.00 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 236.32 | 4,800 | 1,134,328 | 1,300 | 6.1 K to 1.3 K (-78.69 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 235.23 | 6,221 | 1,463,352 | 6,100 | 12.3 K to 6.1 K (-50.49 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.24 | 9,741 | 2,281,767 | 12,321 | 22.1 K to 12.3 K (-44.15 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 233.35 | 4,403 | 1,027,421 | 22,062 | 26.5 K to 22.1 K (-16.64 %) |
Aug 21 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.36 | 3,401 | 790,243 | 26,465 | 29.9 K to 26.5 K (-11.39 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 214.06 | 300 | 64,219 | 0 | 300 to 0 (-100.00 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 212.99 | 1,500 | 319,484 | 300 | 1.8 K to 300 (-83.33 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 211.63 | 1,790 | 378,825 | 1,800 | 3.6 K to 1.8 K (-49.86 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 210.85 | 2,817 | 593,949 | 3,590 | 6.4 K to 3.6 K (-43.97 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 209.56 | 2,298 | 481,556 | 6,407 | 8.7 K to 6.4 K (-26.40 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 216.10 | 1,903 | 411,246 | 0 | 1.9 K to 0 (-100.00 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 215.30 | 5,585 | 1,202,464 | 1,903 | 7.5 K to 1.9 K (-74.59 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 214.44 | 3,743 | 802,654 | 7,488 | 11.2 K to 7.5 K (-33.33 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 213.56 | 800 | 170,846 | 11,231 | 12 K to 11.2 K (-6.65 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 211.93 | 1,731 | 366,854 | 12,031 | 13.8 K to 12 K (-12.58 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 211.01 | 681 | 143,697 | 13,762 | 14.4 K to 13.8 K (-4.72 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 214.00 | 1,200 | 256,803 | 0 | 1.2 K to 0 (-100.00 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 213.36 | 7,482 | 1,596,382 | 1,200 | 8.7 K to 1.2 K (-86.18 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 212.38 | 2,322 | 493,141 | 8,682 | 11 K to 8.7 K (-21.10 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 211.43 | 3,701 | 782,499 | 11,004 | 14.7 K to 11 K (-25.17 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 210.37 | 4,015 | 844,621 | 14,705 | 18.7 K to 14.7 K (-21.45 %) |
Aug 14 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 209.38 | 1,100 | 230,319 | 18,720 | 19.8 K to 18.7 K (-5.55 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 227.01 | 621 | 140,970 | 0 | 621 to 0 (-100.00 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 226.21 | 3,767 | 852,136 | 621 | 4.4 K to 621 (-85.85 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 225.36 | 608 | 137,017 | 4,388 | 5 K to 4.4 K (-12.17 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 224.28 | 1,894 | 424,787 | 4,996 | 6.9 K to 5 K (-27.49 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 223.32 | 2,365 | 528,160 | 6,890 | 9.3 K to 6.9 K (-25.55 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 222.16 | 2,399 | 532,961 | 9,255 | 11.7 K to 9.3 K (-20.59 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 221.33 | 3,600 | 796,769 | 11,654 | 15.3 K to 11.7 K (-23.60 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 220.16 | 1,300 | 286,202 | 15,254 | 16.6 K to 15.3 K (-7.85 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 218.96 | 700 | 153,272 | 16,554 | 17.3 K to 16.6 K (-4.06 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 226.00 | 100 | 22,600 | 0 | 100 to 0 (-100.00 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 225.02 | 300 | 67,507 | 100 | 400 to 100 (-75.00 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 224.05 | 301 | 67,439 | 400 | 701 to 400 (-42.94 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 222.62 | 1,921 | 427,652 | 701 | 2.6 K to 701 (-73.26 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 221.85 | 3,300 | 732,101 | 2,622 | 5.9 K to 2.6 K (-55.72 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 220.63 | 2,209 | 487,360 | 5,922 | 8.1 K to 5.9 K (-27.17 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 219.56 | 2,575 | 565,373 | 8,131 | 10.7 K to 8.1 K (-24.05 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 218.69 | 3,025 | 661,546 | 10,706 | 13.7 K to 10.7 K (-22.03 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 217.73 | 1,369 | 298,068 | 13,731 | 15.1 K to 13.7 K (-9.07 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 216.63 | 283 | 61,305 | 15,100 | 15.4 K to 15.1 K (-1.84 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 225.08 | 300 | 67,524 | 0 | 300 to 0 (-100.00 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 224.23 | 2,400 | 538,150 | 300 | 2.7 K to 300 (-88.89 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 223.46 | 3,107 | 694,301 | 2,700 | 5.8 K to 2.7 K (-53.50 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 222.14 | 3,567 | 792,383 | 5,807 | 9.4 K to 5.8 K (-38.05 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 221.43 | 12,020 | 2,661,547 | 9,374 | 21.4 K to 9.4 K (-56.18 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 220.42 | 2,876 | 633,920 | 21,394 | 24.3 K to 21.4 K (-11.85 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 219.22 | 206 | 45,160 | 24,270 | 24.5 K to 24.3 K (-0.84 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 216.72 | 200 | 43,343 | 24,476 | 24.7 K to 24.5 K (-0.81 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 214.99 | 400 | 85,995 | 24,676 | 25.1 K to 24.7 K (-1.60 %) |
Aug 05 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 212.53 | 100 | 21,253 | 25,076 | 25.2 K to 25.1 K (-0.40 %) |
Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 248.00 | 100 | 24,800 | 0 | 100 to 0 (-100.00 %) |
Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 246.99 | 354 | 87,434 | 100 | 454 to 100 (-77.97 %) |
Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 245.78 | 146 | 35,884 | 454 | 600 to 454 (-24.33 %) |
Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 244.63 | 300 | 73,389 | 600 | 900 to 600 (-33.33 %) |
Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 243.36 | 1,000 | 243,355 | 900 | 1.9 K to 900 (-52.63 %) |
Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.62 | 1,900 | 460,985 | 1,900 | 3.8 K to 1.9 K (-50.00 %) |
Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 241.40 | 1,505 | 363,307 | 3,800 | 5.3 K to 3.8 K (-28.37 %) |